Proxima Bio, Inc.PB
SEC Form D filing

Proxima Bio, Inc.

Biotech · Growth · Regulation D 506(b) · NY · Filed June 10, 2026

Offering amount
$91.5M
Exemption
Reg D 506(b)
Issuer state
NY
Filing date
June 10, 2026
Signature date
June 10, 2026
CIK
0002104665

Summary

Auto-generated

biotech company, $91.5M growth round in NY

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.